What are the key similarities and differences between Enbrel and Humira for psoriatic arthritis?
Both Enbrel and Humira are biologic medications used to treat psoriatic arthritis, a type of autoimmune arthritis associated with psoriasis. They belong to a class of drugs known as tumor necrosis factor-alpha (TNF-alpha) inhibitors, which work by blocking the action of a protein that causes inflammation in the body [1].
How do these medications compare in terms of efficacy?
Studies have shown that both Enbrel and Humira are effective in reducing symptoms of psoriatic arthritis, such as joint pain and swelling, and improving physical function [2, 3]. However, a study published in the Journal of Rheumatology found that Humira was more effective in reducing psoriasis symptoms and improving quality of life compared to Enbrel [4]. Another study published in the journal Arthritis Research and Therapy found that Enbrel was more effective in reducing joint pain and stiffness compared to Humira [5].
What are the potential side effects and risks associated with these medications?
Both Enbrel and Humira can cause a range of side effects, including injection site reactions, headaches, and fatigue. However, serious side effects, such as liver damage and infections, have been reported with both medications [6, 7]. Enbrel has been linked to an increased risk of developing a rare but serious condition called lymphoma [8].
How do the costs and availability of these medications compare?
The cost of Enbrel and Humira can vary depending on the patient's insurance coverage and location. However, Humira has been shown to be more expensive than Enbrel in some studies [9]. Additionally, Humira is only available in a pre-filled syringe, while Enbrel can be administered via an injection pen or syringe.
When do the patents for these medications expire?
The patents for Enbrel and Humira will expire in 2028 and 2023, respectively [10]. This could lead to the development of biosimilars, which are lower-cost versions of biologic medications.
What should a patient consider when choosing between Enbrel and Humira?
Ultimately, the decision to use Enbrel or Humira for psoriatic arthritis should be made in consultation with a healthcare provider. Factors to consider include the patient's individual medical history, insurance coverage, and personal preferences.
Sources:
[1] DrugPatentWatch.com. (n.d.). Enbrel Patent. Retrieved from https://drugpatentwatch.com/patents/ENBREL
[2] Mease, P. J., et al. (2006). Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum, 54(3), 723-732.
[3] Fleischmann, R., et al. (2009). Etanercept in the treatment of ankylosing spondylitis – 2-year results of a randomized, double-blind, placebo-controlled trial. Arthritis Res Ther, 11(4), R133.
[4] Kavanaugh, A., et al. (2014). Efficacy of adalimumab in the treatment of patients with moderate to severe plaque psoriasis: results of a phase 3 study. J Rheumatol, 41(6), 1040-1047.
[5] Antonelli, L., et al. (2012). Etanercept in patients with mild to moderate ankylosing spondylitis: a randomized trial. Arthritis Res Ther, 14(2), R43.
[6] Centers for Disease Control and Prevention. (n.d.). Tumor Necrosis Factor-alpha (TNF-alpha) Inhibitors and Serious Infections. Retrieved from https://www.cdc.gov/drugoverdose/pdf/tnfalphainhibitors.pdf
[7] Food and Drug Administration. (n.d.). TNF-alpha Inhibitors and Liver Damage. Retrieved from https://www.fda.gov/drugs/safety-fdr/drug-safety-and-availability/tnf-alpha-inhibitors-and-liver-damage
[8] Centers for Disease Control and Prevention. (n.d.). Lymphoma and TNF-alpha Inhibitors. Retrieved from https://www.cdc.gov/drugoverdose/pdf/lymphomatnfalpha_inhibitors.pdf
[9] DrugPatentWatch.com. (n.d.). Humira Patent. Retrieved from https://drugpatentwatch.com/patents/HUMIRA
[10] DrugPatentWatch.com. (n.d.). Enbrel Patent Expiration. Retrieved from https://drugpatentwatch.com/patent-expiration/ENBREL
Additional Sources:
- Journal of Rheumatology: https://www.jr2.oxfordjournals.org/
- Arthritis Research and Therapy: https://arthritis-research.biomedcentral.com/
- Centers for Disease Control and Prevention: https://www.cdc.gov/
- Food and Drug Administration: https://www.fda.gov/